Skip to main content
Clinical Trials/ACTRN12613000590763
ACTRN12613000590763
Completed
Not Applicable

To explore safety, feasibility and acceptability of mobile teledermoscopy for Queensland residents 50-64 years at high risk for melanoma.

Queensland University of Technology (QUT), Institute of Health and Biomedical Innovation (IHBI)0 sites50 target enrollmentMay 24, 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Skin CancerMelanoma
Sponsor
Queensland University of Technology (QUT), Institute of Health and Biomedical Innovation (IHBI)
Enrollment
50
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 24, 2013
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Queensland University of Technology (QUT), Institute of Health and Biomedical Innovation (IHBI)

Eligibility Criteria

Inclusion Criteria

  • Inclusion criteria include: Male and female between 50\-64 years of age in Queensland. Previous melanoma or skin cancer diagnosis, fair skin or high number of moles. In addition, stratified sampling will ascertain that 50% of participants will have a history of checking their own skin, whilst the other 50% will have no record of SSE. All participants must be able to speak English to give informed consent. Participants must have access to a smartphone.

Exclusion Criteria

  • People who do not have access to an iPhone, People who have cognitive impairment that prevents them from providing informed consent, People who do not speak English for informed consent, those living outside of Queensland and not available for a visit to QUT for a skin exam.

Outcomes

Primary Outcomes

Not specified

Similar Trials